MANFIDOKIMAB
UNII FQ7M3IAT8U

Substance Identification & Data

This profile provides standardized clinical and technical data for Manfidokimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FQ7M3IAT8U.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2428381-56-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
FQ7M3IAT8U
CAS Registry Number
2428381-56-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
MANFIDOKIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11811
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Manfidokimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MANFIDOKIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4 (224-PROLINE), ANTI-(HUMAN INTERLEUKIN 4 RECEPTOR SUBUNIT .ALPHA.) (HUMAN-MUS MUSCULUS MONOCLONAL AK120 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL AK120 .KAPPA.-CHAIN, DIMER
MANFIDOKIMAB [INN]
MANFIDOKIMAB [WHO-DD]